Encompass Health Co. (NYSE:EHC – Get Free Report) saw a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,350,000 shares, a growth of 6.3% from the December 31st total of 1,270,000 shares. Currently, 1.4% of the company’s shares are short sold. Based on an average daily trading volume, of 649,300 shares, the short-interest ratio is presently 2.1 days.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on EHC shares. Barclays raised their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada boosted their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, KeyCorp increased their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Encompass Health presently has an average rating of “Buy” and a consensus target price of $107.11.
Read Our Latest Stock Analysis on Encompass Health
Encompass Health Stock Up 0.5 %
Institutional Investors Weigh In On Encompass Health
Several institutional investors have recently modified their holdings of EHC. State Street Corp lifted its holdings in Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company’s stock worth $292,410,000 after buying an additional 21,329 shares during the last quarter. Geode Capital Management LLC lifted its stake in Encompass Health by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company’s stock worth $161,781,000 after purchasing an additional 20,547 shares during the last quarter. Copeland Capital Management LLC boosted its holdings in Encompass Health by 0.7% in the fourth quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company’s stock valued at $119,418,000 after purchasing an additional 8,548 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in Encompass Health by 2,458.5% during the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock worth $83,990,000 after purchasing an additional 835,135 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Encompass Health by 0.4% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 769,716 shares of the company’s stock worth $71,083,000 after buying an additional 2,904 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Further Reading
- Five stocks we like better than Encompass Health
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Quiet Period Expirations Explained
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
- How to Invest in Biotech Stocks
- High-Yield Dividend King PepsiCo Offers Value Too Good to Ignore
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.